Donor-Specific Cell Free DNA Monitoring of Thoracic Allografts

Overview

About this study

The purpose of this study is to determine if DNA originating from the transplanted heart or lung can be detected in the blood and used to monitor for rejection.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Please contact the study team to discuss whether or not you are eligible to participate in a study.

Inclusion Criteria:

  • All lung and heart transplant recipients will be eligible.
  • Each participant will be required to provide written informed consent. 

Exclusion Criteria:

  • None.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Mark Wylam, M.D.

Contact us for the latest status

Contact information:

Mark Wylam M.D.

(507) 266-0707

Wylam.Mark@mayo.edu

Jacksonville, Fla.

Mayo Clinic principal investigator

Mark Wylam, M.D.

Contact us for the latest status

Contact information:

David Erasmus M.B., Ch.B., M.D.

(904)956-3271

Erasmus.David@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available